Effect of rofecoxib on expressions of VEGF and inducible NOS in human gastric carcinoma tissues established in nude mice by orthotopic transplantation

孙永强; 王强; 郑国静; 孙溪

您当前的位置：

首页 >

文章列表页 >

Effect of rofecoxib on expressions of VEGF and inducible NOS in human gastric carcinoma tissues established in nude mice by orthotopic transplantation

更新时间：2026-01-09

- Effect of rofecoxib on expressions of VEGF and inducible NOS in human gastric carcinoma tissues established in nude mice by orthotopic transplantation
- Journal of Army Medical University Vol. 29, Issue 10, Pages: 929-931(2007)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  CLC： R73-361;R730.23;R735.2
- Published：2007
- 稿件说明：
移动端阅览
孙永强,王强,郑国静,孙溪.罗非昔布对裸鼠人胃癌原位种植瘤组织中血管内皮生长因子和诱导型一氧化氮合酶表达的影响[J].陆军军医大学学报(原第三军医大学学报),2007,29(10):929-931.

　SUN Yong-qiang,WANG Qiang,ZHENG Guo-jing,SUN Xi.Effect of rofecoxib on expressions of VEGF and inducible NOS in human gastric carcinoma tissues established in nude mice by orthotopic transplantation[J].J Amry Med Univ (J Third Mil Med Univ),2007,29(10):929-931.
孙永强,王强,郑国静,孙溪.罗非昔布对裸鼠人胃癌原位种植瘤组织中血管内皮生长因子和诱导型一氧化氮合酶表达的影响[J].陆军军医大学学报(原第三军医大学学报),2007,29(10):929-931. DOI：

　SUN Yong-qiang,WANG Qiang,ZHENG Guo-jing,SUN Xi.Effect of rofecoxib on expressions of VEGF and inducible NOS in human gastric carcinoma tissues established in nude mice by orthotopic transplantation[J].J Amry Med Univ (J Third Mil Med Univ),2007,29(10):929-931. DOI：

摘要

目的探讨罗非昔布对裸鼠人胃癌原位种植瘤组织中血管内皮生长因子（vascular endothelial growth factor

VEGF）、诱导型一氧化氮合酶（inducible nitric oxide synthase

iNOS）表达的影响。方法建立裸鼠人胃癌原位种植转移模型，以罗非昔布给裸鼠灌胃，通过免疫组化Envision法检测罗非昔布对原位种植瘤胃癌组织中VEGF、iNOS蛋白的表达。结果 VEGF的表达：对照组VEGF阳性率为81.25%，罗非昔布组为61.25%，联合组为35.00%，罗非昔布组与对照组相比，差异有显著性(P0.05)，联合组与罗非昔布组相比，差异有显著性(P0.05)。iNOS的表达显示：对照组iNOS阳性率为73.75%，罗非昔布组为52.50%，联合组为26.67%，罗非昔布组与对照组相比，差异有显著性(P0.05)。结论环氧合酶-2抑制剂罗非昔布可能通过降低胃癌肿瘤组织中 VEGF、iNOS的表达，使肿瘤血管生成受抑，从而抑制胃癌细胞的生长和转移。

Abstract

Objective To evaluate the inhibitory effect of rofecoxib in human gastric carcinoma tissues established in nude mice by orthotopic transplantation through the expressions of vascular endothelial growth factor (VEGF) and inducible nitric oxide synthase (iNOS). Methods After the models of human gastric carcinoma in nude mice by orthotopic transplantation were established

rofecoxib was administered intragastrically. The expressions of VEGF and iNOS were evaluated in the local tumors by Envision immunohistochemical method. Results The expression of VEGF protein in isotonic saline group， rofecoxib group and combination group were 81.25%， 61.25%

and 35.00% respectively．There was significant difference between rofecoxib group and isotonic saline group

and so was rofecoxib group and combination group (P0.05)． The expression of iNOS protein in isotonic saline group，rofecoxib group and combination group was 73.75%，52.50%

and 26.67% respectively

being significantly different among groups (P0.05)． Conclusion Rofecoxib

by downregulating the protein expression of VEGF and iNOS

may suppress the angiogenesis and further the growth and metastasis of gastric carcinoma．

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Molecular mechanism of Zic3 controlling embryonic cerebrovascular development via non-classical Wnt and VEGF signaling axes in zebrafish

Efficacy and safety evaluation of docetaxel liposome inarabbit model bearing orthotopically transplanted VX2 tumor

Increased number of microglia and enhanced expression of inflammatory factors in the hippocampus of rat model of depression

Differential expression of DAB2IP in gastric carcinoma patients with different clinical prognoses

Synergistic effect of VEGF and TGF-β1 in osteogenic differentiation of rabbit bone marrow-derived mesenchymal stem cells

Related Author

Shuaiting LI

Yunpeng WANG

Zhi YUAN

Yeqi WANG

Zhi CHENG

Huizhe HUANG

Yu LIU

Fujun ZHANG

Related Institution

Department of Developmental Biology, Reproductive Medicine Center, the Second Affiliated Hospital of Chongqing Medical University

College of Biological Engineering, Chongqing University

Department of Pharmacy, the First Affiliated Hospital of Chongqing Medical University

Department of Oral and Maxillofacial Surgery, the First Affiliated Hospital of Chongqing Medical University

Department of Pharmaceutical Chemistry and Biological Materials, College of Pharmacy, Chongqing Medical University

⁰